The Next Biggest Bull Run In Over 50 Years

Gold has hit all-time highs, breaking $4,000 an ounce - but history shows it could be on the verge of its biggest bull run in over half a century... triggered by a likely major event, eerily similar to what happened in the 1970s. (It's NOT inflation or anything you're likely expecting.) Now, a top analyst says you can capture ALL of the upside without touching a risky miner or a boring exchange-traded fund. He sees extraordinary potential gains long term with very little risk.

ARGX
Argen X SE ADR
NASDAQ
921.8
Open 915.36 Prev Close 915.36
High 934.62 Low 914.87
Volume 378,775 Volume (Avg) 365
52 Week High 934.62 52 Week Low 510.06
Market Cap 56.8B PE Ratio 46.86

Shares Stats

Shares Outstanding61,570,000
Shares Float61,380,000
Shares Short1,840,000
Insider Holdings0%
Institution Holdings50.94%

About Argen X SE ADR

argenx SE, a commercial-stage biopharma company, develops various therapies for the treatment of autoimmune diseases in the United States, Japan, China, the Netherlands, and internationally. The company offers VYGART and VYGART HYTRULO to treat generalized myasthenia gravis (gMG), immune thrombocytopenia (ITP), and chronic inflammatory demyelinating polyneuropathy (CIDP). It also develops efgartigimod for the treatment of seronegative and ocular gMG, thyroid eye diseases, ITP, myositis, Sjögren's disease, lupus nephropathy, systemic sclerosis, antibody-mediated rejection, and autoimmune encephalitis; empasiprubart for multifocal motor neuropath, CIDP, delayed graft function, and dermatomyositis; and ARGX-119 for congenital myasthenic syndrome, amyotrophic lateral sclerosis, and spinal muscular atrophy. In addition, the company is also developing ARGX-119, a MuSK agonist to treat congenital myasthenic syndromes and amyotrophic lateral sclerosis; ARGX-109, which targets IL-6 to treat inflammation; ARGX-121 and ARGX 220 that targets the immune system; ARGX-213, which targets FcRn; and ARGX-118, which develops antibodies against Galectin-10, as well as cusatuzumab, ARGX-112, ARGX-114, and ARGX-115. It has strategic collaborations with OncoVerity, Inc, LEO Pharma A/S, Zai Lab Limited, AbbVie, Inc., Elektrofi, Genmab SE, Chugai Pharmaceutical Co., Ltd., Clayton Foundation, Halozyme Therapeutics, Inc., AgomAb Therapeutics NV, Broteio Pharma B.V., VIB vzw, University of Texas, BioWa, Inc., Lonza Sales AG, Université Catholique de Louvain, Sopartec S.A., NYU Langone Health, Leiden University Medical Center, and IQVIA Ltd. argenx SE was incorporated in 2008 and is based in Amsterdam, the Netherlands.

General

NameArgen X SE ADR
TickerARGX
ExchangeNASDAQ
SectorHealthcare
IndustryBiotechnology
CurrencyUSD
CountryUSA
Fiscal Year EndDecember
Full Time Employees1,599

Highlights

Analyst Target960.21
Market Cap56,755,200,000
PE Ratio46.86
PEG Ratio1.00
EBITDA721,409,472

Financials

Curr Year EPS Estimate15.01
Next Quarter EPS Estimate4.34
Profit Margin41.87%
Operating Margin12.89
Return on Assets0.05
Return on Equity0.25
Revenue3.1B
Earnings Per Share23.89
Revenue Per Share2.42
Gross Profit2,020,001,024
Quarterly Revenue Growth0.96

Valuation

Trailing PE38.32
Forward PE30.86
Price/Sales (Trailing 12 Mt.)15.48
Price/Book (Most Recent Quarter)9.21

Earnings

Most Popular

AutoZone Set For Solid Quarter As Consumer Demand Rebounds: Analyst

AutoZone shares were little changed as a JPMorgan analyst highlighted resilient demand, improving comps and stronger long-term earnings power.

How To Earn $500 A Month From Dollar General Stock Ahead Of Q3 Earnings

Dollar General offers an annual dividend yield of 2.14% ($2.36 a year). How can investors exploit this to pocket a regular $500 monthly?

They've Done It 20+ Times-Now They've Found a New Memecoin to Watch - Ad

Our analysts have built one of the most reliable track records in the memecoin space by recognizing early momentum signals many traders overlook. Their newest pick shows several of the same early indicators found in past standout performers. Get the details before this story spreads.

What to know about missing Malaysian Airlines Flight MH370 as search resumes

KUALA LUMPUR, Malaysia (AP) — More than a decade ago, Malaysia Airlines Flight MH370 vanished without a trace, sparking one of aviation’s most baffling mysteries.

The $43B Big Pharma Story is Starting Over-With a New Player - Ad

Big Pharma once paid $43B for a small biotech with a similar platform. Now, a new company is following that same playbook, leveraging its patented delivery technology to attract partnerships and near-term revenue potential.

Costco becomes biggest company yet to demand refund of Trump tariffs

WASHINGTON (AP) — Costco is joining other companies that aren't waiting to see President Donald Trump's most sweeping import taxes. They're going to court to demand refunds on the tariffs they've paid.

Marjorie Taylor Greene Goes Bargain Shopping, Discloses Buying These Two Stocks At 52-Week Lows

Congresswoman Marjorie Taylor Greene disclosed some new stocks recently. Unlike past trades in 2024 and 2025, the latest disclosure is rather unique.

Real-Time Finance Hits Wall Street - Ad

A new ETF built for the payments revolution is now trading. Seconds-level settlement and a 0.50% fee* make it one of the cleanest structures yet.

Trump attacks ABC News correspondent Mary Bruce in angry response to three sharp questions

NEW YORK (AP) — President Donald Trump denounced ABC News' Mary Bruce as a “terrible reporter” Tuesday and threatened the network's license to broadcast after she asked him three sharp questions at the White House.

Scaramucci Says This One US Mistake Helped China Become a Manufacturing Superpower

Anthony Scaramucci recently highlighted what he considers a significant error by the US that enabled China to ascend as a manufacturing superpower.

3 Companies Nvidia Needs for their $24 Trillion Conquest - Ad

Nvidia's charging into two seismic tech frontiers projected to be worth over $24 TRILLION! And they're in a race to dominate first. But here's the dirty secret Nvidia won't admit... They can't do it alone. Nvidia needs 3 Silent Partners... This $24 trillion pivot hinges on them.

Copper Is Tight, Silver Is Rising - And This Early Nevada Play Hits the Timing Perfectly - Ad

AI, electrification, battery storage, and data centers are pushing copper and silver demand sharply higher, even as supply stays tight. This region in Nevada offers rare multi-metal potential, and a new company has secured land in a district the surging district. It's one of the cleanest timing setups in the sector right now.

Trump says he's rebuilding Dulles airport while his administration is fixing the 'people movers'

WASHINGTON (AP) — President Donald Trump said Tuesday that his administration will embark on a reconstruction of Dulles International Airport in northern Virginia.

US air travelers without REAL IDs will be charged a $45 fee

Air travelers in the U.S. without a will be charged a $45 fee beginning in February, the Transportation Security Administration announced Monday.

The New Payments ETF Is Live on NASDAQ: - Ad

Money is moving to real-time rails, and a newly listed ETF now gives investors direct exposure. Fast settlement. Institutional custody. Simple access.

The Repeatable Strategy Behind 20+ Early Memecoin Wins (Revealed) - Ad

Few analysts have been able to consistently spot strong memecoin setups, but our team has developed a repeatable framework that has helped them identify high-momentum plays early. Now they've uncovered a new project showing similar characteristics, and they want you to see the full breakdown yourself.

Samsung Vs Apple: The Foldable Phone War Just Went Nuclear

Samsung just launched a game-changing foldable phone, putting pressure on Apple's rumored foldable iPhone. Will foldables become mainstream?

Nvidia's Most Valuable List for 2026 - Ad

Many companies partnering with Nvidia have seen their own stocks go up... That includes ASML, up 4,501%... Synopsys, up 3,745%. And Taiwan Semiconductor, which has soared as much as 9,793%. You won't find these companies anywhere in Nvidia's official Partner Network. That's why I call them Nvidia's "Unauthorized" Silent Partners. In 2026, a new set of them is poised to benefit.

Trump Signs Law to Launch Dollar 2.0 - Ad

Trump just signed law S.1582, unleashing the biggest money shift in 100+ years. For the first time since 1913, private firms - not the Fed - can mint a "Dollar 2.0." Treasury says it could drain $6.6T from banks and pay 10X current savings rates. Early investors in minting firms could see 40X returns by 2032.

Iran confirms seizure of oil tanker in the Strait of Hormuz

TEHRAN, Iran (AP) — Iran on Saturday confirmed as it traveled through the narrow Strait of Hormuz over violations including carrying an illegal consignment, state media reported.

The Next Biggest Bull Run In Over 50 Years - Ad

Gold has hit all-time highs, breaking $4,000 an ounce - but history shows it could be on the verge of its biggest bull run in over half a century... triggered by a likely major event, eerily similar to what happened in the 1970s. (It's NOT inflation or anything you're likely expecting.) Now, a top analyst says you can capture ALL of the upside without touching a risky miner or a boring exchange-traded fund. He sees extraordinary potential gains long term with very little risk.

Nvidia, Dell, Coinbase, Gorilla Technology And Archer Aviation: Why These 5 Stocks Are On Investors' Radars Today

U.S. stocks closed lower on Monday, with the Dow slipping 1.2% to 46,590.24, the S&P 500 easing 0.92% to 6,672.41, and the Nasdaq dipping 0.84% to 22,708.07. These are the top stocks that gained the attention of retail traders and investors through the day:

They've Done It 20+ Times-Now They've Found a New Memecoin to Watch - Ad

Our analysts have built one of the most reliable track records in the memecoin space by recognizing early momentum signals many traders overlook. Their newest pick shows several of the same early indicators found in past standout performers. Get the details before this story spreads.

Trump's $2,000 Tariff Dividend Stumbles On Math: Cost Far Exceeds Revenue

Trump's $2,000 tariff rebate plan faces a major math gap, with estimated costs up to $606.8B—far exceeding tariff revenues in 2025 and 2026, says the Tax Foundation.

The $43B Big Pharma Story is Starting Over-With a New Player - Ad

Big Pharma once paid $43B for a small biotech with a similar platform. Now, a new company is following that same playbook, leveraging its patented delivery technology to attract partnerships and near-term revenue potential.

Trump Bars South Africa From 2026 G20 Summit In Florida, Freezes Aid Over 'White Genocide'

President Donald Trump directed that South Africa will not be invited to the 2026 G20 Summit in Miami, Florida. He also declared that all U.S. payments and subsidies to the country would be immediately suspended.

(Micro)Strategy's Structural Reset: Why Markets Are Repricing MSTR Beyond Bitcoin

The recent decline in Strategy's (NASDAQ:MSTR) stock price is not a simple pullback, nor is it a reaction driven by short-term sentiment. What is unfolding around MSTR is a broad structural repricing.

Real-Time Finance Hits Wall Street - Ad

A new ETF built for the payments revolution is now trading. Seconds-level settlement and a 0.50% fee* make it one of the cleanest structures yet.

Micron Kills 'Crucial' Consumer Unit To Chase AI Gold Rush

Micron Technology, Inc. (NASDAQ: MU) slides after exiting Crucial consumer business to focus on AI-driven data center demand.

Most Recent

Information, charts or examples are for illustration and educational purposes only and not for individualized investment management This message contains commercial elements, such as advertising. We only send these offers to those who have opted in to our newsletter. Past performance is not indicative of future results. For these reasons we strongly suggest trading in a DEMO/Simulated account. The information provided by us is for educational and informational purposes only. We make no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended and have not determined if the statements and opinions of the advertiser are accurate, correct or truthful. If you use, act upon or make decisions in reliance on information contained or any external source linked within it, you do so at your own peril and agree to hold us, our officers, directors, shareholders, affiliates and agents without fault.

Copyright trendadvisor.net
Privacy Policy | Terms of Service